Document is current
Any future updates will be listed below
-
Authors
Kivitz, Alan J.
FitzGerald, Oliver
Nash, Peter
Pang, Shirley
Azevedo, Valderilio F.
Wang, Cunshan
Takiya, Liza https://orcid.org/0000-0002-6296-7685
-
Funding
Funding for this research was provided by:
Pfizer Inc
- License Information
-
More Information
Article History
Received: 26 February 2021
Revised: 23 August 2021
Accepted: 24 August 2021
First Online: 12 September 2021
Declarations
:
: All persons gave their informed consent prior to their inclusion in the study.
: Not applicable.
: AJK has been a consultant for AbbVie, Genentech, Genzyme, Janssen, Novartis, Pfizer Inc., Sanofi-Regeneron, and UCB and has been involved in speakers’ bureaus for Celgene, Genentech, Genzyme, Horizon, Novartis, Pfizer Inc., and Sanofi-Regeneron. OF has received research grants from AbbVie, Bristol-Myers Squibb, Novartis, and Pfizer Inc. and has been a consultant for AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc., and UCB. PN has received research grants and honoraria for lectures and advice on behalf of AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Roche, Sanofi, Pfizer Inc., and UCB and has received consulting fees from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, MSD, Novartis, Pfizer Inc., Sun Pharma, and UCB. SP has been involved in speakers’ bureaus for Celgene and Novartis. VFA has been a consultant for AbbVie, Eli Lilly, Genentech, GSK, Pfizer Inc., and UCB and has been involved in speakers’ bureaus for AbbVie, Janssen, Merck-Serono, Novartis, Pfizer Inc., and Sanofi. CW and LT are employees and shareholders of Pfizer Inc.
